Parkinson’s
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial (PubMed)
- Prospects for cannabinoid therapies in basal ganglia disorders (PubMed)
- Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties (PubMed)
- Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease (PubMed)
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movementsleep behaviour disorder in Parkinson’s disease patients: a case series (PubMed)
- Cannabidiol for the treatment of psychosis in Parkinson’s disease (PubMed)
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease (PubMed)
- Therapeutic potential of cannabinoids in CNS disease (PubMed)
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series (Journal of Clinical Pharmacy and Therapeutics)
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial (Journal of Psychopharmacology
- Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection (Molecular Neurodegeneration)
- The influence of cannabinoids on generic traits of neurodegeneration (British Journal of Pharmacology)